Dose-dependent reduced haloperidol/haloperidol ratios: influence of patient-related variables-Reference-Cited by-同舟云学术

Dose-dependent reduced haloperidol/haloperidol ratios: influence of patient-related variables

Published:1997-09 Issue:2 Volume:72 Page:127-132
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Lane Hsien-Yuan,Chang Wen-Ho,Chang Yue-Cune,Yoa-Pu Hu Oliver,Lin Hsin-Nan,Jann Michael W,Hu Wei-Herng

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference34 articles.

1. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia: with particular reference to drug resistance;Altamura;Schizophrenia Research,1993

2. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D2 receptor;Bowen;European Journal of Pharmacology,1990

3. Haloperidol and reduced haloperidol induced exacerbation of the dystonia produced by Kappa opioid U50,488H in guinea pigs correlate with inhibition of sigma binding sites;Brent;Neuropsychopharmacology,1994

4. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?;Chang;Psychopharmacology,1992

5. Low plasma reduced haloperidol/haloperidol ratios in Chinese patients;Chang;Biological Psychiatry,1987

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipsychotic drug toxicology in children;Expert Opinion on Drug Metabolism & Toxicology;2011-03-15

2. Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction;Analytical and Bioanalytical Chemistry;2006-09-07

3. Haloperidol in palliative care;Palliative Medicine;2004-04

4. Poor Reliability of Therapeutic Drug Monitoring Data for Haloperidol and Bromperidol Using Enzyme Immunoassay;Therapeutic Drug Monitoring;2003-12

5. The impact of the polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment;Clinical Pharmacology & Therapeutics;2002-10